# Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients

> **NCT05033925** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Gadjah Mada University** · enrollment: 324 (estimated)

## Conditions studied

- Breast Cancer Stage IV

## Interventions

- **DIETARY_SUPPLEMENT:** FADA (active fraction of Ficus septica leaf) 800 mg/day
- **DIETARY_SUPPLEMENT:** FADA (active fraction of Ficus septica leaf) 2000 mg/day
- **OTHER:** Placebo capsule

## Key facts

- **NCT ID:** NCT05033925
- **Lead sponsor:** Gadjah Mada University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-25
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 324 (ESTIMATED)
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05033925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05033925, "Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05033925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*